Mason Street Advisors’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-13,027
| Closed | -$116K | – | 217 |
|
|
2020
Q4 | $116K | Sell |
13,027
-80
| -0.6% | -$651 | ﹤0.01% | 1476 |
|
|
2020
Q3 | $85K | Sell |
13,107
-957
| -7% | -$6.07K | ﹤0.01% | 1467 |
|
|
2020
Q2 | $87K | Buy |
14,064
+1,219
| +9% | +$7.48K | ﹤0.01% | 1465 |
|
|
2020
Q1 | $87K | Hold |
12,845
| – | – | ﹤0.01% | 1438 |
|
|
2019
Q4 | $149K | Buy |
12,845
+319
| +3% | +$3.6K | ﹤0.01% | 1440 |
|
|
2019
Q3 | $129K | Buy |
12,526
+234
| +2% | +$2.3K | ﹤0.01% | 1442 |
|
|
2019
Q2 | $115K | Buy |
12,292
+685
| +6% | +$5.27K | ﹤0.01% | 1448 |
|
|
2019
Q1 | $82K | Buy |
11,607
+349
| +3% | +$2.99K | ﹤0.01% | 1537 |
|
|
2018
Q4 | $83K | Buy |
11,258
+504
| +5% | +$4.22K | ﹤0.01% | 1483 |
|
|
2018
Q3 | $94K | Buy |
10,754
+243
| +2% | +$2.48K | ﹤0.01% | 1487 |
|
|
2018
Q2 | $118K | Buy |
10,511
+404
| +4% | +$4.82K | ﹤0.01% | 1473 |
|
|
2018
Q1 | $112K | Buy |
10,107
+619
| +7% | +$7.76K | ﹤0.01% | 1463 |
|
|
2017
Q4 | $121K | Buy |
9,488
+245
| +3% | +$3.24K | ﹤0.01% | 1437 |
|
|
2017
Q3 | $132K | Buy |
9,243
+1,426
| +18% | +$17.9K | ﹤0.01% | 1404 |
|
|
2017
Q2 | $101K | Buy |
7,817
+104
| +1% | +$1.34K | ﹤0.01% | 1439 |
|
|
2017
Q1 | $111K | Buy |
7,713
+499
| +7% | +$7.35K | ﹤0.01% | 1417 |
|
|
2016
Q4 | $113K | Buy |
7,214
+424
| +6% | +$5.81K | ﹤0.01% | 1404 |
|
|
2016
Q3 | $80K | Buy |
6,790
+385
| +6% | +$5.07K | ﹤0.01% | 1426 |
|
|
2016
Q2 | $89K | Buy |
6,405
+615
| +11% | +$8.15K | ﹤0.01% | 1381 |
|
|
2016
Q1 | $67K | Buy |
5,790
+540
| +10% | +$6.86K | ﹤0.01% | 1410 |
|
|
2015
Q4 | $86K | Buy |
5,250
+500
| +11% | +$7.95K | ﹤0.01% | 1353 |
|
|
2015
Q3 | $65K | Buy |
4,750
+573
| +14% | +$7.78K | ﹤0.01% | 1380 |
|
|
2015
Q2 | $53K | Buy |
4,177
+192
| +5% | +$2.18K | ﹤0.01% | 1442 |
|
|
2015
Q1 | $47K | Buy |
3,985
+205
| +5% | +$2.35K | ﹤0.01% | 1450 |
|
|
2014
Q4 | $47K | Buy |
3,780
+115
| +3% | +$1.18K | ﹤0.01% | 1848 |
|
|
2014
Q3 | $34K | Buy |
3,665
+278
| +8% | +$2.13K | ﹤0.01% | 1865 |
|
|
2014
Q2 | $22K | Buy |
3,387
+85
| +3% | +$562 | ﹤0.01% | 1885 |
|
|
2014
Q1 | $27K | Sell |
3,302
-1,000
| -23% | -$9.84K | ﹤0.01% | 1851 |
|
|
2013
Q4 | $43K | Buy |
4,302
+326
| +8% | +$2.26K | ﹤0.01% | 1829 |
|
|
2013
Q3 | $24K | Sell |
3,976
-306
| -7% | -$1.75K | ﹤0.01% | 1739 |
|
|
2013
Q2 | $22K | Buy |
+4,282
| New | +$21.9K | ﹤0.01% | 1692 |
|
Other funds holding CCRN
ACB
SFM
RA
Mason Street Advisors's CCRN Position: Q1 2021 in Review
Mason Street Advisors sold out of Cross Country Healthcare (CCRN) in Q1 2021, closing a stake of 13,027 shares — an estimated $116K sold.
Mason Street Advisors first reported a position in CCRN in Q2 2013 and held it in 31 quarters. The position peaked at $149K in Q4 2019. 129 funds tracked by Wall St. Rank hold CCRN as of Q1 2021.
- Mason Street Advisors reported no remaining Cross Country Healthcare position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 13,027 Cross Country Healthcare shares in Q1 2021, an estimated $116K.
- Mason Street Advisors first reported a position in Cross Country Healthcare in Q2 2013 and held it in 31 quarters.
- Mason Street Advisors's Cross Country Healthcare position peaked at $149K in Q4 2019.
- 129 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.